Zoom Communications, Inc.

Zoom's stake in AI startup Anthropic could be worth between $2 billion and $4 billion if chatbot developer Claude goes public

An analyst found a "hidden treasure" in Zoom. Its shares rose to a 3.5-year high

Apple Inc.

JPMorgan Chase & Co.

Investment bank expects pressure on Apple's margins due to memory price hikes to start to abate

JPMorgan expects Apple's profits to rise due to strong iPhone demand. What will the report show?

Corvus Pharmaceuticals, Inc.

Trinseo PLC

Freedom Broker has named the two stocks from the smid-cap-tracking Russell 2000 index with best and worst performance from January 9 through January 22. The former was recorded by Corvus Pharmaceuticals, which is developing a drug for atopic dermatitis, while the worst performer was Trinseo, a producer of specialty materials for the construction and automotive industries.

Freedom names biggest small-cap winner and loser in last two weeks

Meta Platforms, Inc.

Meta will unveil a new AI model in the first quarter of 2026: this could push the stock higher

Jefferies called Meta stock a better idea after an 18% decline. Why should you buy them?

Microsoft Corporation

NVIDIA Corporation

ChatGPT developer 'falling apart in real time', says ex-Fidelity executive George Noble

'Falling apart before our eyes': Wall Street veteran warns against OpenAI-related stocks

Biohaven Ltd.

Investment bank RBC Capital Markets <a href="https://www.cnbc.com/2026/01/21/this-biotech-stock-has-plummeted-over-the-past-year-rbc-says-it-sees-a-big-gain-ahead.html">upgraded</a>&nbsp;to "outperform"&nbsp;its rating on shares of Biohaven Ltd, a small cap developer of drugs for epilepsy and kidney disease. The upgrade follows new clinical data that, in RBC’s view, reduces development risk and improves the risk-reward profile. The bank now sees potential for the stock to rise 70% from current levels.

RBC Capital upgrades TP and rating on small-cap biotech Biohaven, seeing 70% upside

Alphabet Inc.

The beginning of the reporting season can give a positive impetus to the securities of US bigtechs, says Nationwide strategist 

Mag7 shares have been lagging the market for months now. Is it time to buy them?

Netflix, Inc.

Wall Street considers Netflix's advertising business in particular to be undervalued

'Temporary weakness': analysts advised to buy Netflix stock on the downturn

Marvell Technology, Inc.

Adobe Inc.

Salesforce, Inc.

In a particularly vulnerable position is OpenAI

'The honeymoon is over': Deutsche Bank warns of 'most challenging year ever' for AI

Ramaco Resources, Inc.

MP Materials Corp.

Investment bank Jefferies has upgraded to "buy"&nbsp;its rating on shares of small-cap company Ramaco Resources, which is developing a rare earth metals deposit. China remains the dominant player in the market, and strained relations between China and the U.S. over recent months have created opportunities for companies such as Ramaco, <i>Barron's </i><a href="https://www.barrons.com/articles/ramaco-stock-upgrade-rare-earths-49586e9a?mod=RTA">notes</a>.

Jefferies upgrades rare earth miner Ramaco to 'buy' after slide in last 3 months

Resideo Technologies, Inc.

Amentum Holdings, Inc.

Mayville Engineering Company, Inc.

Royce Investment Partners, founded by Wall Street <a href="https://oninvest.com/article/kak-investirovat-v-small-cap-pat-covetov-ot-caka-rojsa-legendy-uoll-strit">legend</a>&nbsp;Chuck Royce, has specialized in small-cap investing since 1972. Over that period, Royce <a href="https://www.royceinvest.com/funds/">built</a>&nbsp;a broad lineup of funds focused on micro-cap, small-cap, and mid-cap stocks. Chuck Royce’s investment philosophy has historically centered on undervalued small-cap businesses with sustainable operations, strong balance sheets, and visible cash flows – an approach that remains evident in the firm’s portfolios.

Industry, Energy, IT: Royce's small-cap investment ideas for 2026

Forum Energy Technologies, Inc.

Array Technologies, Inc.

Harrow, Inc.

Five9, Inc.

GigaCloud Technology Inc.

Research outfit Zacks has <a href="https://www.zacks.com/featured-articles/301/best-small-cap-stocks">named</a>&nbsp;five small-cap stocks that investors should pay attention to in January, including both “buy” and “hold” ratings. According to Zacks, these stocks have been delivering earnings above Wall Street forecasts, a signal that the earnings outlook may be improving.

Investment ideas